Karen Bick Sells 6,062 Shares of Ralliant (NYSE:RAL) Stock

Ralliant Corporation (NYSE:RAL) SVP Karen Bick sold 6,062 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. This represents a 16.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ralliant Trading Down 3.5%

NYSE:RAL traded down $2.54 during mid-day trading on Tuesday, hitting $69.42. 1,336,205 shares of the company’s stock were exchanged, compared to its average volume of 1,694,804. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $75.41. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $7.68 billion, a P/E ratio of -6.40, a PEG ratio of 2.69 and a beta of 1.61. The company has a 50 day simple moving average of $68.82 and a 200-day simple moving average of $55.58.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, research analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current year.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s dividend payout ratio (DPR) is currently -1.84%.

Analyst Ratings Changes

Several brokerages have recently weighed in on RAL. Truist Financial restated a “buy” rating and set a $82.00 price objective (up from $68.00) on shares of Ralliant in a research report on Friday, July 31st. TD Cowen increased their target price on shares of Ralliant from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a report on Friday, July 31st. Royal Bank Of Canada boosted their price target on shares of Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a research report on Friday, July 31st. Finally, Evercore initiated coverage on shares of Ralliant in a research report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Ralliant presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.70.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Danske Bank A S bought a new stake in shares of Ralliant during the 4th quarter valued at about $25,000. Dunhill Financial LLC bought a new stake in Ralliant in the second quarter worth approximately $25,000. Allworth Financial LP increased its holdings in Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares in the last quarter. Palisade Asset Management LLC acquired a new position in Ralliant in the third quarter valued at approximately $26,000. Finally, BOKF NA acquired a new position in Ralliant in the third quarter valued at approximately $29,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.